| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6015885 | Epilepsy Research | 2013 | 7 Pages |
Abstract
The study confirms that the release of cf-DNA is more active in symptomatic refractory focal epilepsy, whereas this process is less pronounced in patients with unknown cause of epilepsy.
Keywords
cf-DNAOLEUGT1A1S-100BTLEFLEiNOSIL1-RaNSEAEDTBIPLEcell-free DNANeuron-specific enolaseTraumatic brain injuryInterleukin 1 receptor antagonisthippocampal sclerosisinflammationMRIstandard deviationinterleukinCeliac diseaseMagnetic resonance imagingNeurodegenerationtumor necrosis factor-αantiepileptic drugCNSEtiologyinducible nitric oxide synthasecentral nervous systemFrontal Lobe Epilepsytemporal lobe epilepsyParietal lobe epilepsyoccipital lobe epilepsyFocal epilepsyTNF-αS-100B protein
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Suvi P. Liimatainen, Juulia Jylhävä, Jani Raitanen, Jukka T. Peltola, Mikko A. Hurme,